Consistent with increased frequencies of CD27+ T cells in C-GBM tumors, elevated CD27 expression on CD4+, DNT, and CD8+ T cells correlated with worse prognosis and favored patients with C-GBM tumors (Supplemental Figure 11, M–O). This evidence concerns the gene CD27 and glioblastoma.